Singapore, Sept. 1 -- A session billed as a conversation about partnering was, on closer inspection, something rather more useful: a pricing signal, delivered by the only people in the room who set prices.

Before a word was spoken, this session had already told you something. Look at who was sitting up there, and then look at who was not.

The panel on APAC dealmaking brought together Irene Hong, Founding Partner at CEC Capital; Tom Wu, Head of Ventures for Asia Pacific at AbbVie; Martin Taylor, Principal at F-Prime Capital; Derek Yuan, Partner at Venrock; and James Huang, Founder and Managing Partner at Panacea Capital.

Advisory, corporate venture, two US venture franchises and a dedicated Asia healthcare fund. Every seat was on the ca...